Literature DB >> 22009161

A diagnostic algorithm--the holy grail of primary aldosteronism.

Gian Paolo Rossi, Teresa Maria Seccia, Achille C Pessina.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22009161     DOI： 10.1038/nrendo.2011.180

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

2.  Adrenal gland: uncertainty in the selective use of adrenal vein sampling.

Authors:  Klara J Rosenquist; Robert G Dluhy
Journal:  Nat Rev Endocrinol       Date:  2011-06-21       Impact factor: 43.330

Review 3.  Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.

Authors:  I Irony; C E Kater; E G Biglieri; C H Shackleton
Journal:  Am J Hypertens       Date:  1990-07       Impact factor: 2.689

4.  Reliability of screening methods for the diagnosis of primary aldosteronism.

Authors:  D H Streeten; N Tomycz; G H Anderson
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

5.  Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma.

Authors:  J L Phillips; M M Walther; J C Pezzullo; W Rayford; P L Choyke; A A Berman; W M Linehan; J L Doppman; J R Gill
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

6.  Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.

Authors:  Tetsuo Nishikawa; Masao Omura; Fumitoshi Satoh; Hirotaka Shibata; Katsutoshi Takahashi; Naohisa Tamura; Akiyo Tanabe
Journal:  Endocr J       Date:  2011-08-09       Impact factor: 2.349

7.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

8.  Further evaluation of saline infusion for the diagnosis of primary aldosteronism.

Authors:  O B Holland; H Brown; L Kuhnert; C Fairchild; M Risk; C E Gomez-Sanchez
Journal:  Hypertension       Date:  1984 Sep-Oct       Impact factor: 10.190

9.  Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma.

Authors:  Gian Paolo Rossi; Anna Belfiore; Giampaolo Bernini; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Gaetana Palumbo; Damiano Rizzoni; Ermanno Rossi; Enrico Agabiti-Rosei; Achille C Pessina; Franco Mantero
Journal:  Hypertension       Date:  2007-06-25       Impact factor: 10.190

10.  Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.

Authors:  R D Gordon; C E Gomez-Sanchez; S M Hamlet; T J Tunny; S A Klemm
Journal:  J Hypertens Suppl       Date:  1987-12
  10 in total
  12 in total

1.  Outcome of surgical treatment of primary aldosteronism.

Authors:  Marilisa Citton; Giovanni Viel; Gian Paolo Rossi; Franco Mantero; Donato Nitti; Maurizio Iacobone
Journal:  Langenbecks Arch Surg       Date:  2015-01-08       Impact factor: 3.445

2.  A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.

Authors:  Evangelia Charmandari; Amalia Sertedaki; Tomoshige Kino; Christina Merakou; Dax A Hoffman; Michael M Hatch; Darrell E Hurt; Lin Lin; Paraskevi Xekouki; Constantine A Stratakis; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2012-05-24       Impact factor: 5.958

Review 3.  Approach to the surgical management of primary aldosteronism.

Authors:  Maurizio Iacobone; Marilisa Citton; Giovanni Viel; Gian Paolo Rossi; Donato Nitti
Journal:  Gland Surg       Date:  2015-02

4.  Clinical management of primary aldosteronism: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA).

Authors:  Gian Paolo Rossi; Anna Dalla Cà
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-25

5.  Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.

Authors:  Amalia Sertedaki; Athina Markou; Dimitrios Vlachakis; Sophia Kossida; Emilie Campanac; Dax A Hoffman; Maria De La Luz Sierra; Paraskevi Xekouki; Constantine A Stratakis; Gregory Kaltsas; George P Piaditis; George P Chrousos; Evangelia Charmandari
Journal:  Clin Endocrinol (Oxf)       Date:  2016-07-12       Impact factor: 3.478

Review 6.  The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

7.  Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.

Authors:  Giuseppe Maiolino; Giacomo Rossitto; Valeria Bisogni; Maurizio Cesari; Teresa Maria Seccia; Mario Plebani; Gian Paolo Rossi
Journal:  J Am Heart Assoc       Date:  2017-05-21       Impact factor: 5.501

8.  Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy.

Authors:  Chia-Hui Chang; Ya-Hui Hu; Yao-Chou Tsai; Che-Hsiung Wu; Shuo-Meng Wang; Lian-Yu Lin; Yen-Hung Lin; Fumitoshi Satoh; Kwan-Dun Wu; Vin-Cent Wu
Journal:  Oncotarget       Date:  2017-05-02

9.  Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism.

Authors:  Marilisa Citton; Giovanni Viel; Francesca Torresan; Gian Paolo Rossi; Maurizio Iacobone
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

10.  A clinical prediction score for diagnosing unilateral primary aldosteronism may not be generalizable.

Authors:  Erik S Venos; Benny So; Valerian C Dias; Adrian Harvey; Janice L Pasieka; Gregory A Kline
Journal:  BMC Endocr Disord       Date:  2014-12-11       Impact factor: 2.763
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.